Clinical trial
TheraGauze™ Alone and Regranex®Gel 0.01% Plus TheraGauze™ in the Treatment of…
NCT00389636 · Solsys Medical LLC, Industry · Unknown status
Key facts
| NCT number | NCT00389636 |
|---|---|
| Title | TheraGauze™ Alone and Regranex®Gel 0.01% Plus TheraGauze™ in the Treatment of Wagner Stage I Diabetic Foot Ulcers |
| Official title | TheraGauze™ Alone and Regranex®Gel 0.01% Plus TheraGauze™ in the Treatment of Wagner Stage I Diabetic Foot Ulcers |
| Lead sponsor | Solsys Medical LLC, Industry |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Diabetic Foot Ulcer |
| Intervention type | Device, Drug |
| Interventions | TheraGauze, Regranex |
| Enrollment | 30 |
| Start date | Sep 1, 2006 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Oct 19, 2006 |
| Last update posted | May 7, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: